Lecture 7 - Autoimmune Diseases Flashcards

1
Q

What are the criteria for autoimmune disease?

A
  1. Auto-antibodies or auto-reactive T cells found in disease
  2. Auto-antibodies/T cells found at site of damage (organ)
  3. Level of auto-antibody or T cell response reflect disease activity
  4. Reduction of antibody or T cell response leads to reduction of disease
  5. Transfer of autoantibody or T cell to another host leads to disease in recipient
  6. Immunization with autoantigen causes disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List the possible triggers for autoimmunity

A
  • Cross reactivity with microbial antigen
  • Sequestered antigen
  • Polyclonal activation
  • Non-infectious triggers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the mechanisms of central self tolerance?

A

Central:
– Receptor editing
– Deletion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the mechanisms of peripheral self tolerance?

A
Peripheral:
– Anergy 
– Clonal Ignorance 
– T  regulator cell
– Fas – Fas L mediated apoptosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What ENA are associated with SLE?

A
  • dsDNA (90% of SLE)
  • Smith Ag (5 - 40% of SLE)
  • Nucleosomes - histone & dsDNA (40 - 70% of SLE)
  • Proliferating cell nuclear antigen (3% of SLE)
  • Ribosomal P protein (10% of SLE)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What two mechanisms that explain the possible cause of SLE?

A
  • SLE people may have defective mechanism of clearing DNA after apoptosis, so exposing the DNA as antigen
  • SLE may in part be due to Langerhans cell dysfunction
  • Drugs may trigger SLE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the antigen that the auto-antibodies are directed against in Goodpasture’s syndrome?

A

α3 chain of collagen type IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are blocking and binding antibodies in relation to Pernicious anaemia?

A
  • Blocking: binds the intrinsic factor to B12

- Binding: binds the intrinsic factor to the ileal receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do anti-parietal cell antibodies (APC) come about and what part do they play in the immunopathology of Pernicious anaemia?

A
  • Anti-parietal cell antibody found in 90% of cases of pernicious anaemia
  • Antigen is gastric proton pump ATPase
  • Not involved in Pathology of disease since antigen is not exposed in vivo? – Damaged parietal cells leads to reduction of intrinsic factor production and so reduction of B12 absorption.
  • Damage to parietal cells may expose antigen to immune system and so production of APC?
  • Used as screening test
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Diabetes mellitus type 1

A
  • Young <40
  • Normal/low weight
  • Caucasian
  • Abrupt onset
  • Lack of insulin
  • Autoimmune
  • Weak genetic component
  • 10% of Diabetes patients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the immunopathology of Diabetes mellitus type 1.

A
  • Destruction of the β-cells of islets of langerhans in pancreas
  • Cytotoxic T cells and cytokines
  • Followed by auto-antibodies – Anti-Islet cell antibodies (ICA)
  • β-cells responsible for insulin production

• Auto-antigens:
– Glutamic acid decarboxylase (GAD)
– Tyrosine phosphatase (IA-2) – Insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the acute and long term complications of Diabetes mellitus type 1?

A

• Ketoacidosis

– Due to lack of insulin there is unrestrained lipolysis and in adipose tissue

– Elevated levels of circulating fatty acids resulting in elevated ketone body production by the liver (metabolic carboxylic acids)

– Excess accumulation of metabolic acids

– Metabolic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Celiac disease is a response to gluten. What is the main protein component of gluten that is the antigen in this disease and what is the enzyme that process it.

A

• Main protein involved in the development of Celiac disease in gluten is α-gliadin

• The enzyme tissue transglutaminase (tTG) modifies (deamination) α-gliadin
– Converts glutamine to negatively charged glutamic acid
– This modified protein leads to disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why are people that are HLA-DQ2 more prone to getting Celiac disease.

A
  • The modified α-gliadin binds to the unique peptide-binding grove of HLA-DQ2 (on APC)
  • This then activates CD4 T cells (to induce a specific antiα-gliadin response)

– Activated CD4 T cells produce INF-ɣ and TNF leading to inflammation

– Activated CD4 T cells kill epithelial cells by binding Fas (apoptosis)

– Activation of Cytotoxic T cells (CD8) and NK cells

• Presence of α-gliadin in epithelial cells causes stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the immunopathology of celiac disease

A

• Celiac disease is not strictly an autoimmune disease

– Entirely dependant on a foreign antigen (gluten)
– No specific immune response to self antigen causing illness
– But has features of an autoimmune disease

• Antibodies are made against tissue transglutaminase (tTG)

– Gluten can complex with tTG and be taken up by B cells
– Activated T cells can provide help
– Production of anti-tTG antibodies
– No evidence that these antibodies contribute to disease
– Serum anti-tTG IgA antibody test specific for Celiac disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Antibodies involved in Hashimoto’s thyroiditis

A

– Anti-thyroglobulin antibodies
• Precursor of thyroglobulin
• Over 90% of patients with Hashimoto’s

– Anti-thyroid peroxidase (anti-TPO) antibodies
• > 80% of patients with Hashimoto’s

17
Q

Clinical presentation of Hashimoto’s thyroiditis

A
  • Early in disease there may be extra release of T3/T4 due to damage and compensation (Appears like Hyperthyroidism)
  • Onset 30 -60 years, females (7 X more than Males)
  • HLA-DR3, 4, 5 associated, while DQ1 protective
  • Goiter - enlarged thyroid (compensatory)
  • Fatigue, dry coarse cold skin, weight gain, mild depression, slow speech and movement
  • Myxoedema (puffy face, pasty skin, large tongue)
18
Q

Hashimoto’s thyroiditis (diagnosis and treatment)

A
  • Low T4 and elevated TSH – (T3 sometimes low)
  • ELISA (or other) for anti-thyroglobulin and/or anti-TPO
  • Treated with Thyroglobulin (T3 and T4) replacement therapy
19
Q

Diabetes mellitus type 2

A
  • Middle age / older >40
  • Overweight
  • All races (indigenous Australian at higher risk)
  • Slow onset
  • Insulin resistance
  • Probably a variety of mechanisms
  • Strong genetic component
  • 90% of Diabetes patients
20
Q

Ketoacidosis

A

• Symptoms
– Nausea (vomiting), confusion, thirst, headache, abdominal pain, drowsiness, acetone breath, dehydration
– Ketone bodies in urine, lowered blood pH, hyperventilation

• Treatment
– IV insulin
– IV fluids (saline)

21
Q

Ketoacidosis

A

• Symptoms
– Nausea (vomiting), confusion, thirst, headache, abdominal pain, drowsiness, acetone breath, dehydration
– Ketone bodies in urine, lowered blood pH, hyperventilation

• Treatment
– IV insulin
– IV fluids (saline)

22
Q

MHC

A
  • Strongest association with autoimmune diseases
  • HLA contributes approx 50% of genetic susceptibility in most autoimmune diseases
  • The strongest association is between HLA-B27 and ankylosing spondylitis
23
Q

Non-HLA genes

A
  • PTPN22
  • IL10
  • BLK
  • IL2RA
  • NOD2
24
Q

PTPN22

A

Function: Protein tyrosine phosphatase (T & B cell signalling)

Disease: RA, Type 1 diabetes, Inflammatory bowel disease

25
Q

IL10

A

Function: Immune suppression - down regulate costimulatory molecules, inhibits TH1

Disease: Inflammatory bowel disease, SLE, Type 1 diabetes

26
Q

BLK

A

Function: B cell tyrosine kinase (B cell activation)

Disease: SLE, RA

27
Q

IL2RA

A

Function: IL-2 receptor chain (T cell activation)

Disease: Multiple sclerosis, type 1 diabetes

28
Q

NOD2

A

Function: Cytoplasmic sensor of bacteria

Disease: Inflammatory bowel disease

29
Q

NOD2

A

Function: Cytoplasmic sensor of bacteria

Disease: Inflammatory bowel disease

30
Q

Tolerance

A

• Tolerance – unresponsiveness to an antigen that is induced by previous exposure to that antigen

• Central Tolerance – during lymphocyte maturation
– Bone marrow for B cells, Thymus for T cells

• Peripheral Tolerance – mature lymphocytes
– Tissue specific self tolerance